THE STUDY
In the selection of the participants of the Delphi process some issues are raised: 1. Why only UK experts and not international as well? 2. Why the skewed representation of different specialties in the expert selection? 3. Did the different specialities reply differently to the questions raised? 4. How did you define "demonstrable improvement" to select the experts? What makes people qualify as ERAS experts in this paperplease define and motivate.
Methods description: 5. It is recommended that the authors define "future improvements" that makes up for the selection of choices of techniques that were up for discussion. (as opposed to available or old (?) techniques). 6. It is not clear why the authors choose to ask this question supposing greater use if laparoscopic surgery. Especially since only colorectal surgeons felt this would be of major benefit for the outcomes... 7. The authors are recommended to explain how they made the selection of choices of techniques that have been proposed in ERAS protocols since a long time, such as CHO and yet leaving out several other elements or techniques known to have an impact on outcomes, including withholding from smoking and excessive alcohol etc.
The study is UK based throughout and UK experts from the ER program were invited to participate. As outlined above, it is not perfectly clear how this selection was made and why certain choices were made and how this may have impacted the results. This needs clarification and motivation.
Although mentioned in the sustainability part of the study, the auditing of the elements making up the best practice or ERAS protocol was not included as a potential factor for outcomes and improvements. This is surprising given the data on the important of this in the literature. This merits comment.
Minor issues:
The abbreviations CPEX and DOSA are explained only late and under a table, while it should be given in the text as well when first used.
Given that the authors address the above issues, the paper could merit a second chance. 
REVIEWER

GENERAL COMMENTS
Overall I find that most of this paper is of limited interest to a general non-UK reader. The exception is the sections on perioperative items and their perceived importance in the future. This is definitely interesting from a strong panel like this.The "aim" is vaguely phrased. I do not get (after three readings) what the authors are actually trying to assess. This issue reemerges in the discussions of the two non-surgical sections (patient experience & adoption and spread). I would prefer a restructuring with focus on the perioperative items (or a more consise description of aims).
Minor comments:
Results: I do not understand the second percentage (77.1%) it doesn't fit the calculation. Patient experience data: Are the authors describing the current situation, or the preferred situation? CPEX is not written out the first time it appears and needs explaining No supplemental documents.
GENERAL COMMENTS
In this study, Dr. Knott and colleagues have used the Delphi technique to try and determine consensus from experts regarding implementation and sustainability of the Enhanced Recovery After Surgery Programme. The study is well written and is easy to read. It would be improved if the authors could address the following points:
1 Methods: How were the experts chosen and how did the authors determine the sample size? The authors state that 86 experts were recruited, but there were only 70 (71 in the abstract: this dichotomy should be corrected) in round 1. This number reduced to 66 for round 2 and 32 for round 3. What was the reason for this attrition and do the authors think that this could have a bearing on the validity of their results?
2. The study was completed in Sep 2010. Nearly two year have elapsed since then. Are the responses still valid?
3. The authors should clarify what they mean by "pain busters".
4. The acronym DOSA has not been expanded in the footnote to Table 3 .
5. Fig. 4 : It is not clear from the legend whether the responses represent the opinions of the experts. In addition, percentages and numbers should be provided for the pie charts.
VERSION 1 -AUTHOR RESPONSE
Reviewer 1: Olle Ljungqvist 1. Why only UK experts and not international as well? This article was designed to address a national need to sustain Enhanced Recovery after cessation of the national adoption programme. The drive for this research was from the Cancer Action Team on behalf of NHS Improvement initiative and Department of Health in England. Hence, local experts were recruited with understanding of the local needs to address the problem. This point has been clarified in paragraph 4 of the discussion.
2. Why the skewed representation of different specialties in the expert selection?
The selected expert group represented the current practice in the UK where Enhanced Recovery started in colorectal surgery and expanded to other specialities. Therefore more colorectal teams qualified for the definition of expert than other specialities.
3. Did the different specialities reply differently to the questions raised? Not in the generic ERAS questions.
4. How did you define "demonstrable improvement" to select the experts? Centres that could show a reduction in length of stay of at least 2 days following the implementation of ERAS at their institution. Please see 'Methods' paragraph 2.
5. What makes people qualify as ERAS experts in this paper -please define and motivate. The Enhanced Recovery Partnership Programme defined expert centres as units with established ERAS programmes over 1 year and in at least one specialty. The units had displayed measurable reduction in length of stay of at least 2 days. Experts were selected from these centres based on nomination from their peers within the unit as the leaders of enhanced recovery in the centre. Please see 'Methods' paragraph 2.
6. It is recommended that the authors define "future improvements" that makes up for the selection of choices of techniques that were up for discussion. (as opposed to available or old (?) techniques). Experts were invited to suggest new technologies that they felt would positively impact on ERAS. These are listed in Table 3. 7. It is not clear why the authors choose to ask this question supposing greater use if laparoscopic surgery. Especially since only colorectal surgeons felt this would be of major benefit for the outcomes... This study was conducted prior to the outcome of the LAFA trial, which has found that laparoscopic surgery maximises the benefit of ERAS in a randomised control trial. Interestingly, the expert opinion concurred with this conclusion. An open-ended question was proposed to the expert group asking them to suggest techniques that would positively impact on ERAS in future. The selection of techniques was driven by the expert group and those most frequently suggested were taken forward to the next round for further investigation. Regarding the elements of ERAS, we did not address these in this study. 8. A potential problem (but also a potential strength) with this study is that it takes a very clear UK perspective making it quite specific to the situation there. This is understandable given that it all stems from a UK program of implementation. But this also limits the findings to this perspective. This reviewer would propose that the discussion about epidurals may have a very strong UK angle to it. In Scandinavia where the training, use and efficacy of this method is very high the views are quite likely to be different. The potential failure rates of the technique and its impact on how well the technique is perceived merits comment. We thank the reviewer for their comments. This study focuses mainly on the UK practice, which is moving away from routine use of epidural analgesia following colorectal resections, especially with the widespread adoption of laparoscopic techniques. Understandably, when it is not routinely used this would worsen the success rate, but in centres where epidural is still routinely practiced, a failure rate of 11% has been reported in our recent randomised controlled trial comparing epidural analgesia versus wound infusion catheter. A comment has been added to the discussion to expand on this (paragraph 7).
Epidural vs Continuous Wound Infusion Analgesia following laparoscopic colonic resection: A double blinded randomised controlled pilot trial. Boulind CE, Ewings P, Bulley SH, Kennedy RH, Blazeby JM; Francis NK. Accepted in BJS July 2012 (in press).
9. This Delphi study from the UK expertise involved in the NHS Enhanced Recovery Program shows that among them there is agreement to form a national society on enhanced recovery, that certain elements will improve ERAS further (selective cardiopulmonary exercise testing, and Doppler monitoring in selected patients) and secure sustainability of good results (regular follow ups in teams and audit including patient experiences). The report also shows that there were some issue were consensus was not reached; the general use of Doppler, regional anesthesia and the use of minimal invasive surgery (some possibly due to different views in specialties), but also in a range of other items proposed in the early phase of the study. This indicates the need for future research. We agree with the reviewer 10. The study is UK based throughout and UK experts from the ER program were invited to participate. As outlined above, it is not perfectly clear how this selection was made and why certain choices were made and how this may have impacted the results. This needs clarification and motivation. This has been addressed above in question 5.
11. Although mentioned in the sustainability part of the study, the auditing of the elements making up the best practice or ERAS protocol was not included as a potential factor for outcomes and improvements. This is surprising given the data on the important of this in the literature. This merits comment.
On the second round of the study, the experts were asked to select all the options that they felt should be measured when auditing enhanced recovery. Options included compliance with ERAS elements, clinical outcomes and patient experience (see appendix 1). The expert group choose to focus on measuring clinical outcomes such as re-admission, complication rates and patient experience. This may reflect the local need to measure those items, rather than measuring compliance with ERAS elements, which have been already addressed by the partnership programme.
12. Minor issues: The abbreviations CPEX and DOSA are explained only late and under a table, while it should be given in the text as well when first used.
